Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 32.85
+0.35 (1.08%)
May 29, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 204.95 | 244.41 | 243.41 | 198.41 | 352 | 196.11 |
Depreciation & Amortization | 181.51 | 183.14 | 182.96 | 181.96 | 176.28 | 179.75 |
Loss (Gain) From Sale of Assets | - | 0.09 | -0.17 | -6.1 | 0.05 | 0.15 |
Loss (Gain) From Sale of Investments | 11.76 | 14.3 | 23.07 | 1.85 | -70.49 | 2.22 |
Provision & Write-off of Bad Debts | 0.01 | -0.01 | -2.67 | 78.83 | 2.14 | 1.97 |
Other Operating Activities | 29.79 | 24.07 | 27.53 | 2.43 | 4.54 | 44.65 |
Change in Accounts Receivable | 13.25 | 19.06 | -52.17 | -61.46 | -29.37 | 12.95 |
Change in Inventory | -46.17 | -43.39 | 75.44 | 71.53 | -130.21 | 80.13 |
Change in Accounts Payable | -21.8 | 1.12 | 43.77 | -87.53 | 30.33 | 36.01 |
Change in Unearned Revenue | -11.37 | -2.48 | -4.07 | -14.53 | 10.95 | 10.17 |
Change in Other Net Operating Assets | -3.11 | 23.76 | -70.67 | -22.78 | 22.97 | -7.47 |
Operating Cash Flow | 358.82 | 464.08 | 466.43 | 342.61 | 369.19 | 556.63 |
Operating Cash Flow Growth | -32.24% | -0.50% | 36.14% | -7.20% | -33.67% | 268.61% |
Capital Expenditures | -317.16 | -277.82 | -524.6 | -297.51 | -93.84 | -156.05 |
Sale of Property, Plant & Equipment | - | - | 16.01 | 6.53 | 0.24 | 0.05 |
Sale (Purchase) of Intangibles | -3.85 | -3.22 | -1.32 | -3.22 | -0.33 | -3.69 |
Investment in Securities | - | - | 135 | -33.75 | 1.78 | -129.2 |
Other Investing Activities | -5.19 | -0.89 | 2.51 | -1.55 | -17.7 | -2.59 |
Investing Cash Flow | -326.2 | -281.94 | -372.39 | -329.51 | -109.85 | -291.48 |
Short-Term Debt Issued | - | 3,770 | 2,220 | 2,520 | 2,810 | 2,475 |
Long-Term Debt Issued | - | 28.78 | 175.22 | - | - | - |
Total Debt Issued | 4,139 | 3,799 | 2,395 | 2,520 | 2,810 | 2,475 |
Short-Term Debt Repaid | - | -3,760 | -2,350 | -2,310 | -2,920 | -2,375 |
Long-Term Debt Repaid | - | -21.32 | -13.94 | -13.55 | -13.8 | -52.9 |
Total Debt Repaid | -4,051 | -3,781 | -2,364 | -2,324 | -2,934 | -2,428 |
Net Debt Issued (Repaid) | 87.42 | 17.46 | 31.28 | 196.45 | -123.8 | 47.1 |
Common Dividends Paid | -161.58 | -161.58 | -201.98 | -232.27 | -181.78 | -161.58 |
Other Financing Activities | 6.3 | 6.11 | -0.27 | 0.06 | 30.27 | - |
Financing Cash Flow | -67.86 | -138.02 | -170.97 | -35.77 | -275.31 | -114.48 |
Foreign Exchange Rate Adjustments | - | - | -0 | -0.06 | 0.06 | -0.01 |
Net Cash Flow | -35.24 | 44.13 | -76.93 | -22.73 | -15.92 | 150.66 |
Free Cash Flow | 41.65 | 186.25 | -58.17 | 45.1 | 275.35 | 400.58 |
Free Cash Flow Growth | 59.61% | - | - | -83.62% | -31.26% | 558.08% |
Free Cash Flow Margin | 1.97% | 8.61% | -2.64% | 2.10% | 14.19% | 22.50% |
Free Cash Flow Per Share | 0.41 | 1.84 | -0.57 | 0.45 | 2.72 | 3.96 |
Cash Interest Paid | 8.46 | 8.46 | 5.6 | 7.06 | 4.81 | 3.5 |
Cash Income Tax Paid | 34.23 | 34.23 | 33.88 | 83.07 | 44.65 | 16.14 |
Levered Free Cash Flow | -120.76 | 12.29 | -165.25 | 150.61 | 192.96 | 332.75 |
Unlevered Free Cash Flow | -115.36 | 17.66 | -161.79 | 155.1 | 195.98 | 334.96 |
Change in Working Capital | -69.2 | -1.93 | -7.7 | -114.77 | -95.34 | 131.79 |